Aspira women's health to present at the cancer advocacy group of louisiana's 3rd annual neauxcancer conference

Austin, texas, feb. 22, 2024 (globe newswire) -- aspira women's health inc. (“aspira” or the “company”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at the cancer advocacy group of louisiana's 3rd annual neauxcancer conference taking place in new orleans, louisiana on february 29 to march 2, 2024. management will be available for one-on-one meetings with investors who are registered for the conference.
AWH Ratings Summary
AWH Quant Ranking